
Jennifer Doan
Examiner (ID: 2317, Phone: (571)272-2346 , Office: P/2883 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2883, 2874 |
| Total Applications | 1999 |
| Issued Applications | 1770 |
| Pending Applications | 114 |
| Abandoned Applications | 149 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6918765
[patent_doc_number] => 20050096326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Substituted indian derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/807918
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12046
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807918 | Substituted indian derivatives | Mar 23, 2004 | Abandoned |
Array
(
[id] => 7208826
[patent_doc_number] => 20050043533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Process for making alpha-substituted hydroxamic acids'
[patent_app_type] => utility
[patent_app_number] => 10/807884
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33949
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807884
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807884 | Process for making alpha-substituted hydroxamic acids | Mar 23, 2004 | Abandoned |
Array
(
[id] => 7256732
[patent_doc_number] => 20050143392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Chrysogenazine obtained from fungus Penicillium chrysogenum having antibacterial activity'
[patent_app_type] => utility
[patent_app_number] => 10/804201
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3476
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143392.pdf
[firstpage_image] =>[orig_patent_app_number] => 10804201
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/804201 | Chrysogenazine obtained from fungus Penicillium chrysogenum having antibacterial activity | Mar 18, 2004 | Abandoned |
Array
(
[id] => 5890045
[patent_doc_number] => 20060276485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/550222
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14497
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276485.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550222
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550222 | Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators | Mar 18, 2004 | Abandoned |
Array
(
[id] => 5154940
[patent_doc_number] => 20070037823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/549942
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13954
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037823.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549942 | Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators | Mar 18, 2004 | Abandoned |
Array
(
[id] => 7410700
[patent_doc_number] => 20040176388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Piperazine derivatives as 5-HT1B antagonists'
[patent_app_type] => new
[patent_app_number] => 10/802236
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11879
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176388.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802236
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802236 | Piperazine derivatives as 5-HT1B antagonists | Mar 16, 2004 | Abandoned |
Array
(
[id] => 435931
[patent_doc_number] => 07262188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Phenyl sulfone derivatives and their use in the treatment of CNS disorders'
[patent_app_type] => utility
[patent_app_number] => 10/547987
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3836
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/262/07262188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547987
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547987 | Phenyl sulfone derivatives and their use in the treatment of CNS disorders | Mar 8, 2004 | Issued |
Array
(
[id] => 7337056
[patent_doc_number] => 20040132720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)'
[patent_app_type] => new
[patent_app_number] => 10/471432
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10437
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471432 | Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity) | Mar 8, 2004 | Abandoned |
Array
(
[id] => 510688
[patent_doc_number] => 07196088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-27
[patent_title] => 'Substituted tetrahydroisoquinolines and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/791578
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11304
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/196/07196088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10791578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/791578 | Substituted tetrahydroisoquinolines and uses thereof | Mar 1, 2004 | Issued |
Array
(
[id] => 7190702
[patent_doc_number] => 20040204423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Crystalline antifungal polymorph'
[patent_app_type] => new
[patent_app_number] => 10/786886
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5046
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10786886
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/786886 | Crystalline antifungal polymorph | Feb 24, 2004 | Issued |
Array
(
[id] => 7434642
[patent_doc_number] => 20040162430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity'
[patent_app_type] => new
[patent_app_number] => 10/783109
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6140
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162430.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783109 | Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity | Feb 19, 2004 | Issued |
Array
(
[id] => 7429035
[patent_doc_number] => 20040230056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Process for synthesizing N-aryl piperazines with chiral N\'-1-[benzoyl(2-pyridyl)amino]-2-propane substitution'
[patent_app_type] => new
[patent_app_number] => 10/780972
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3735
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20040230056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780972 | Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution | Feb 17, 2004 | Issued |
Array
(
[id] => 7191842
[patent_doc_number] => 20040204586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Inhibitors of macrophage migration inhibitory factor and methods for identifying the same'
[patent_app_type] => new
[patent_app_number] => 10/778884
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 53017
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778884
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778884 | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same | Feb 12, 2004 | Issued |
Array
(
[id] => 463764
[patent_doc_number] => 07238696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands'
[patent_app_type] => utility
[patent_app_number] => 10/778427
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11175
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238696.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778427 | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | Feb 12, 2004 | Issued |
Array
(
[id] => 1040615
[patent_doc_number] => 06869913
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-22
[patent_title] => 'Pyridazin-3-one derivatives, their use and intermediates for their production'
[patent_app_type] => utility
[patent_app_number] => 10/773231
[patent_app_country] => US
[patent_app_date] => 2004-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102535
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/869/06869913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773231
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773231 | Pyridazin-3-one derivatives, their use and intermediates for their production | Feb 8, 2004 | Issued |
Array
(
[id] => 7239137
[patent_doc_number] => 20040157854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'CCRS antagonists useful for treating aids'
[patent_app_type] => new
[patent_app_number] => 10/773521
[patent_app_country] => US
[patent_app_date] => 2004-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13163
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773521 | CCR5 antagonists useful for treating aids | Feb 5, 2004 | Issued |
Array
(
[id] => 7265053
[patent_doc_number] => 20040242589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => '3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders'
[patent_app_type] => new
[patent_app_number] => 10/486068
[patent_app_country] => US
[patent_app_date] => 2004-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10314
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242589.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486068
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486068 | 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders | Feb 5, 2004 | Abandoned |
Array
(
[id] => 6912969
[patent_doc_number] => 20050176727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Oximes and hydrazones that are useful in treating sexual dysfunction'
[patent_app_type] => utility
[patent_app_number] => 10/773035
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52101
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773035
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773035 | Oximes and hydrazones that are useful in treating sexual dysfunction | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7276407
[patent_doc_number] => 20040235858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents'
[patent_app_type] => new
[patent_app_number] => 10/486025
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6068
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486025 | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents | Feb 4, 2004 | Abandoned |
Array
(
[id] => 606493
[patent_doc_number] => 07153858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-26
[patent_title] => 'Arylpiperazinyl compounds'
[patent_app_type] => utility
[patent_app_number] => 10/768579
[patent_app_country] => US
[patent_app_date] => 2004-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30338
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/153/07153858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10768579
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/768579 | Arylpiperazinyl compounds | Jan 29, 2004 | Issued |